Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 348

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

The effect of methotrexate and anti–tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 PERSON‐YEARS of observation

Wolfe, Frederick, Michaud, Kaleb·2007·Arthritis & Rheumatism

Abstract

Objective: To ascertain the relationship between anti–tumor necrosis factor (anti‐TNF) therapy, methotrexate (MTX), and the risk of lymphoma in patients with rheumatoid arthritis (RA). This report updates our previous report during 29,314 person‐years of followup. Methods: Participants in the National Data Bank for Rheumatic Diseases (NDB) longitudinal study of long‐term outcomes of RA completed semiannual questionnaires from 1998 through 2005, during 89,710 person‐years of followup. Lymphoma reports were validated by medical records. The association between lymphoma and treatment was investigated using conditional logistic regression, adjusted for severity and demographic covariates. Results: Of the 19,591 participants, 55.3% received biologic agents and 68.0% received MTX while enrolled in the NDB. The lymphoma incidence rate was 105.9 (95% confidence interval [95% CI] 86.6–129.5) per 100,000 person‐years of exposure. Compared with the SEER (Surveillance, Epidemiology, and End‐Results) lymphoma database, the standardized incidence ratio was 1.8 (95% CI 1.5–2.2). The odds ratio (OR) for lymphoma in patients who received anti‐TNF therapy compared with patients who did not receive anti‐TNF therapy was 1.0 (95% CI 0.6–1.8 [ P = 0.875]). The OR for lymphoma in patients who received anti‐TNF plus MTX therapy compared with patients who received MTX treatment alone was 1.1 (95% CI 0.6–2.0 [ P = 0.710]). Infliximab and etanercept considered individually also were not associated with a risk of lymphoma. Conclusion: In a study of lymphoma in 19,591 RA patients over 89,710 person‐years of followup, which included exposure to anti‐TNF therapy in 10,815 patients, we did not observe evidence for an increase in the incidence of lymphoma among patients who received anti‐TNF therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.22579

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 348

Metadata

Authors
Wolfe, F., & Michaud, K.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2007-04-27
Volume
56
Issue
5
Pages
1433-1439
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2017281030
Cited by
348
References
1
FWCI
24.82
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effect of methotrexate and anti–tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 PERSON‐YEARS of observation. https://app.cochat.ai/papers/10.1002/art.22579
The paper
Wolfe, F., & Michaud, K. (2007). The effect of methotrexate and anti–tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 PERSON‐YEARS of observation. Arthritis & Rheumatism. https://doi.org/10.1002/art.22579

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.